Larvol Delta - Safety-and-Tolerability-Study-of-SKX16-in-Subjects-With-Moderate-to-Severe-Distal-Subungual-Onychomycosis

luliconazole 10% solution (SKX-16) - Sato Pharma, Bausch Health

http://clinicaltrials.gov/ct2/show/NCT05110638

Aug 22, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next